Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilze Bot

Showing results (21-30 of 127) with videos related to

Pageof 13
Sort By:
Atherosclerosis|December 7, 2010
Atorvastatin inhibits plaque development and adventitial neovascularization in ApoE deficient mice independent of plasma cholesterol levelsIlze Bot, J Wouter Jukema, Inge M Lankhuizen, et al.
Atherosclerosis|March 16, 2019
Reply to: "The "cholesterol paradox" in patients with mastocytosis"Ilze Bot, Monique T Mulder, Swasti Indhirajanti, et al.
Progress in Cardiovascular Diseases|November 25, 2025
Mast cells in cardiovascular disease: Fibrosis, angiogenesis and atherogenesisGabriel Bueno, Ilze Bot, Anish A Kanhai, et al.
Geroscience|July 2, 2025
Immunosenescence accelerates atherosclerosis development in AAV-PCSK9 mouse modelJill de Mol, Virginia Smit, Mireia N A Bernabé Kleijn, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 5, 2013
Myocardin regulates vascular response to injury through miR-24/-29a and platelet-derived growth factor receptor-βAmarnath Talasila, Haixiang Yu, Matthew Ackers-Johnson, et al.
Atherosclerosis|December 12, 2017
Systemic mastocytosis associates with cardiovascular events despite lower plasma lipid levelsSwasti Indhirajanti, Paul L A van Daele, Sven Bos, et al.
Journal of Cellular and Molecular Medicine|August 16, 2014
Complement factor C5a induces atherosclerotic plaque disruptionsAnouk Wezel, Margreet R de Vries, H Maxime Lagraauw, et al.
Molecular Therapy. Nucleic Acids|November 6, 2019
Antisense Oligonucleotide Inhibition of MicroRNA-494 Halts Atherosclerotic Plaque Progression and Promotes Plaque StabilizationEva van Ingen, Amanda C Foks, Mara J Kröner, et al.
Scientific Reports|October 23, 2015
Mesenchymal Stem Cells Reduce Murine Atherosclerosis DevelopmentVanessa Frodermann, Janine van Duijn, Melissa van Pel, et al.
Journal of Immunological Methods|August 27, 2025
In vitro and in vivo lipopolysaccharide-driven activation of human neutrophils in healthy volunteers as a tool for clinical drug developmentHendrika W Grievink, Coen Breedveld, John Öhd, et al.
Pageof 13

Showing results (21-30 of 127) with videos related to

Sort By:
Pageof 13
Atherosclerosis|December 7, 2010
Atorvastatin inhibits plaque development and adventitial neovascularization in ApoE deficient mice independent of plasma cholesterol levelsIlze Bot, J Wouter Jukema, Inge M Lankhuizen, et al.
Atherosclerosis|March 16, 2019
Reply to: "The "cholesterol paradox" in patients with mastocytosis"Ilze Bot, Monique T Mulder, Swasti Indhirajanti, et al.
Progress in Cardiovascular Diseases|November 25, 2025
Mast cells in cardiovascular disease: Fibrosis, angiogenesis and atherogenesisGabriel Bueno, Ilze Bot, Anish A Kanhai, et al.
Geroscience|July 2, 2025
Immunosenescence accelerates atherosclerosis development in AAV-PCSK9 mouse modelJill de Mol, Virginia Smit, Mireia N A Bernabé Kleijn, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 5, 2013
Myocardin regulates vascular response to injury through miR-24/-29a and platelet-derived growth factor receptor-βAmarnath Talasila, Haixiang Yu, Matthew Ackers-Johnson, et al.
Atherosclerosis|December 12, 2017
Systemic mastocytosis associates with cardiovascular events despite lower plasma lipid levelsSwasti Indhirajanti, Paul L A van Daele, Sven Bos, et al.
Journal of Cellular and Molecular Medicine|August 16, 2014
Complement factor C5a induces atherosclerotic plaque disruptionsAnouk Wezel, Margreet R de Vries, H Maxime Lagraauw, et al.
Molecular Therapy. Nucleic Acids|November 6, 2019
Antisense Oligonucleotide Inhibition of MicroRNA-494 Halts Atherosclerotic Plaque Progression and Promotes Plaque StabilizationEva van Ingen, Amanda C Foks, Mara J Kröner, et al.
Scientific Reports|October 23, 2015
Mesenchymal Stem Cells Reduce Murine Atherosclerosis DevelopmentVanessa Frodermann, Janine van Duijn, Melissa van Pel, et al.
Journal of Immunological Methods|August 27, 2025
In vitro and in vivo lipopolysaccharide-driven activation of human neutrophils in healthy volunteers as a tool for clinical drug developmentHendrika W Grievink, Coen Breedveld, John Öhd, et al.
Pageof 13